CLINICAL_TRIALS
trial_result
· 2011-07-04
Clinical Trial Update: A Comparative Study of KSO-0400 in BPH Patients With LUTS [Phase 2]
Summary
Phase 2 comparative study of KSO-0400 in patients with Benign Prostatic Hyperplasia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Benign Prostatic Hyperplasia (BPH) | Phase 2 | Status: COMPLETED